Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.

Clark JC, Thomas DM, Choong PF, Dass CR.

Cancer Metastasis Rev. 2007 Dec;26(3-4):675-83. Review.

PMID:
17828469
2.

Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.

Takemoto N, Tada M, Hida Y, Asano T, Cheng S, Kuramae T, Hamada J, Miyamoto M, Kondo S, Moriuchi T.

Lung Cancer. 2007 Dec;58(3):376-83. Epub 2007 Aug 21.

PMID:
17714826
3.

Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer.

Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y, Morioka Y, Takahashi C, Noda M, Wada H, Tanaka F.

Eur J Cancer. 2004 Jul;40(10):1617-23.

PMID:
15196549
4.

Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.

Oshima T, Kunisaki C, Yoshihara K, Yamada R, Yamamoto N, Sato T, Makino H, Yamagishi S, Nagano Y, Fujii S, Shiozawa M, Akaike M, Wada N, Rino Y, Masuda M, Tanaka K, Imada T.

Oncol Rep. 2008 May;19(5):1285-91.

PMID:
18425389
5.
6.

Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.

Song SY, Son HJ, Nam E, Rhee JC, Park C.

Eur J Cancer. 2006 Jan;42(1):101-8. Epub 2005 Dec 1.

PMID:
16324834
7.

The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.

Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y.

Clin Cancer Res. 2004 Aug 15;10(16):5572-9.

8.
9.

RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.

Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I.

J Orthop Res. 2007 May;25(5):696-702.

10.

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Figueira RC, Gomes LR, Neto JS, Silva FC, Silva ID, Sogayar MC.

BMC Cancer. 2009 Jan 14;9:20. doi: 10.1186/1471-2407-9-20.

11.

Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer.

Takenaka K, Ishikawa S, Yanagihara K, Miyahara R, Hasegawa S, Otake Y, Morioka Y, Takahashi C, Noda M, Ito H, Wada H, Tanaka F.

Ann Surg Oncol. 2005 Oct;12(10):817-24. Epub 2005 Aug 8.

PMID:
16132376
12.

Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.

Liu LT, Chang HC, Chiang LC, Hung WC.

Cancer Res. 2003 Jun 15;63(12):3069-72.

13.

RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.

Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M.

Clin Cancer Res. 2003 May;9(5):1779-84.

14.

RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.

Furumoto K, Arii S, Mori A, Furuyama H, Gorrin Rivas MJ, Nakao T, Isobe N, Murata T, Takahashi C, Noda M, Imamura M.

Hepatology. 2001 Jan;33(1):189-95.

PMID:
11124835
15.

Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.

Cho YB, Lee WY, Song SY, Shin HJ, Yun SH, Chun HK.

Hum Pathol. 2007 Nov;38(11):1603-10. Epub 2007 Jul 31.

PMID:
17669467
16.

Inhibition of histone deacetylase attenuates hypoxia-induced migration and invasion of cancer cells via the restoration of RECK expression.

Jeon HW, Lee YM.

Mol Cancer Ther. 2010 May;9(5):1361-70. doi: 10.1158/1535-7163.MCT-09-0717. Epub 2010 May 4.

18.
19.

Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.

Liu LT, Chang HC, Chiang LC, Hung WC.

Oncogene. 2002 Nov 28;21(54):8347-50.

20.

Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.

Correa TC, Brohem CA, Winnischofer SM, da Silva Cardeal LB, Sasahara RM, Taboga SR, Sogayar MC, Maria-Engler SS.

J Cell Biochem. 2006 Sep 1;99(1):156-67.

PMID:
16791855

Supplemental Content

Support Center